186 related articles for article (PubMed ID: 14615277)
1. Hexarelin protects rat cardiomyocytes from angiotensin II-induced apoptosis in vitro.
Pang JJ; Xu RK; Xu XB; Cao JM; Ni C; Zhu WL; Asotra K; Chen MC; Chen C
Am J Physiol Heart Circ Physiol; 2004 Mar; 286(3):H1063-9. PubMed ID: 14615277
[TBL] [Abstract][Full Text] [Related]
2. Effect of AT(1) receptor blockade on cardiac apoptosis in angiotensin II-induced hypertension.
Diep QN; El Mabrouk M; Yue P; Schiffrin EL
Am J Physiol Heart Circ Physiol; 2002 May; 282(5):H1635-41. PubMed ID: 11959625
[TBL] [Abstract][Full Text] [Related]
3. Dose and time-dependent apoptotic effects by angiotensin II infusion on left ventricular cardiomyocytes.
Fabris B; Candido R; Bortoletto M; Zentilin L; Sandri M; Fior F; Toffoli B; Stebel M; Bardelli M; Belgrado D; Giacca M; Carretta R
J Hypertens; 2007 Jul; 25(7):1481-90. PubMed ID: 17563572
[TBL] [Abstract][Full Text] [Related]
4. Tanshinone IIA attenuates angiotensin II-induced apoptosis via Akt pathway in neonatal rat cardiomyocytes.
HONG HJ; LIU JC; CHENG TH; CHAN P
Acta Pharmacol Sin; 2010 Dec; 31(12):1569-75. PubMed ID: 21102479
[TBL] [Abstract][Full Text] [Related]
5. Ghrelin protects H9c2 cardiomyocytes from angiotensin II-induced apoptosis through the endoplasmic reticulum stress pathway.
Yang C; Wang Y; Liu H; Li N; Sun Y; Liu Z; Yang P
J Cardiovasc Pharmacol; 2012 May; 59(5):465-71. PubMed ID: 22269847
[TBL] [Abstract][Full Text] [Related]
6. Synergism of simvastatin with losartan prevents angiotensin II-induced cardiomyocyte apoptosis in vitro.
Xu J; Lü XW; Huang Y; Zhu PL; Li J
J Pharm Pharmacol; 2009 Apr; 61(4):503-10. PubMed ID: 19298698
[TBL] [Abstract][Full Text] [Related]
7. Hexarelin protects cardiac H9C2 cells from angiotensin II-induced hypertrophy
Agbo E; Li MX; Wang YQ; Saahene RO; Massaro J; Tian GZ
Pharmazie; 2019 Aug; 74(8):485-491. PubMed ID: 31526442
[TBL] [Abstract][Full Text] [Related]
8. Improvement of cardiomyocyte function by in vivo hexarelin treatment in streptozotocin-induced diabetic rats.
Zhang X; Qu L; Chen L; Chen C
Physiol Rep; 2018 Feb; 6(4):. PubMed ID: 29446246
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of lncRNA MEG3 attenuates high glucose-induced cardiomyocytes injury by inhibiting mitochondria-mediated apoptosis pathway.
Zhang WW; Geng X; Zhang WQ
Eur Rev Med Pharmacol Sci; 2019 Sep; 23(17):7599-7604. PubMed ID: 31539151
[TBL] [Abstract][Full Text] [Related]
10. Involvement of Na+/H+ exchanger in hypoxia/re-oxygenation-induced neonatal rat cardiomyocyte apoptosis.
Sun HY; Wang NP; Halkos ME; Kerendi F; Kin H; Wang RX; Guyton RA; Zhao ZQ
Eur J Pharmacol; 2004 Feb; 486(2):121-31. PubMed ID: 14975701
[TBL] [Abstract][Full Text] [Related]
11. Hexarelin suppresses cardiac fibroblast proliferation and collagen synthesis in rat.
Xu X; Pang J; Yin H; Li M; Hao W; Chen C; Cao JM
Am J Physiol Heart Circ Physiol; 2007 Nov; 293(5):H2952-8. PubMed ID: 17766487
[TBL] [Abstract][Full Text] [Related]
12. Antiapoptotic effect of endothelin-1 in rat cardiomyocytes in vitro.
Ogata Y; Takahashi M; Ueno S; Takeuchi K; Okada T; Mano H; Ookawara S; Ozawa K; Berk BC; Ikeda U; Shimada K; Kobayashi E
Hypertension; 2003 May; 41(5):1156-63. PubMed ID: 12668584
[TBL] [Abstract][Full Text] [Related]
13. Nitric oxide-induced apoptosis is mediated by Bax/Bcl-2 gene expression, transition of cytochrome c, and activation of caspase-3 in rat vascular smooth muscle cells.
Chae IH; Park KW; Kim HS; Oh BH
Clin Chim Acta; 2004 Mar; 341(1-2):83-91. PubMed ID: 14967162
[TBL] [Abstract][Full Text] [Related]
14. Protective effect of cholecystokinin octapeptide on angiotensin II-induced apoptosis in H9c2 cardiomyoblast cells.
Wang C; Yu H; Wei L; Zhang J; Hong M; Chen L; Dong X; Fu L
J Cell Biochem; 2020 Jul; 121(7):3560-3569. PubMed ID: 31886572
[TBL] [Abstract][Full Text] [Related]
15. The Growth Hormone Secretagogue Hexarelin Protects Rat Cardiomyocytes From in vivo Ischemia/Reperfusion Injury Through Interleukin-1 Signaling Pathway.
Huang J; Li Y; Zhang J; Liu Y; Lu Q
Int Heart J; 2017 Apr; 58(2):257-263. PubMed ID: 28321024
[TBL] [Abstract][Full Text] [Related]
16. Possible cause of taurine-deficient cardiomyopathy: potentiation of angiotensin II action.
Schaffer S; Solodushko V; Pastukh V; Ricci C; Azuma J
J Cardiovasc Pharmacol; 2003 May; 41(5):751-9. PubMed ID: 12717106
[TBL] [Abstract][Full Text] [Related]
17. Isoflurane inhibits cardiac myocyte apoptosis during oxidative and inflammatory stress by activating Akt and enhancing Bcl-2 expression.
Jamnicki-Abegg M; Weihrauch D; Pagel PS; Kersten JR; Bosnjak ZJ; Warltier DC; Bienengraeber MW
Anesthesiology; 2005 Nov; 103(5):1006-14. PubMed ID: 16249675
[TBL] [Abstract][Full Text] [Related]
18. In vivo study of AT(1) and AT(2) angiotensin receptors in apoptosis in rat blood vessels.
Diep QN; Li JS; Schiffrin EL
Hypertension; 1999 Oct; 34(4 Pt 1):617-24. PubMed ID: 10523336
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin II type-1 receptor-JAK/STAT pathway mediates the induction of visfatin in angiotensin II-induced cardiomyocyte hypertrophy.
Chang L; Yang R; Wang M; Liu J; Wang Y; Zhang H; Li Y
Am J Med Sci; 2012 Mar; 343(3):220-6. PubMed ID: 21841463
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin II does not induce apoptosis but rather prevents apoptosis in cardiomyocytes.
Kong JY; Rabkin SW
Peptides; 2000 Aug; 21(8):1237-47. PubMed ID: 11035211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
